Trademark applications and grants for Cellectis S A. Cellectis S A has 9 trademark applications. The latest application filed is for "CYTOPORATION"
Patent Application | Date |
---|---|
UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS 20210161954 - 16/498899 Smith; Julianne ;   et al. | 2021-06-03 |
NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22 20210100839 - 16/498276 Schiffer-Mannioui; Cecile ;   et al. | 2021-04-08 |
PLANTS FOR PRODUCTION OF THERAPEUTIC PROTEINS 20210059142 - 17/098210 Mathis; Luc ;   et al. | 2021-03-04 |
DYNAMIC MIXING AND ELECTROPORATION CHAMBER AND SYSTEM 20200080073 - 16/655228 King; Alan D. ;   et al. | 2020-03-12 |
Large Volume Ex Vivo Electroporation Method 20180237765 - 15/956103 Walters; Richard E ;   et al. | 2018-08-23 |
SEC | 0001627281 | Cellectis S.A. of FRANCE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.